Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![BeiGene Ltd. Graphic](https://lunarcrush.com/gi/w:26/t:$6160hk.png) BeiGene Ltd.

BeiGene's stock is climbing due to positive sentiment surrounding the ASCO 2025 presentation and pipeline momentum. China's biotech firms are advancing rapidly with AI catching up to US leaders in drug innovation.

### About BeiGene Ltd.
BeiGene Ltd. is a biotechnology company focused on developing and commercializing innovative cancer medicines.  

### Insights [#](/topic/$6160hk/insights)
- BeiGene Ltd. sentiment is up XX% from the previous week.
- BeiGene Ltd. creators is up XXXXX% from the previous week.
- BeiGene Ltd. engagements is up XX% from the previous week.
- BeiGene Ltd. mentions is up XX% from the previous week.
- BeiGene Ltd. posts created is up XXX% from the previous week.
- BeiGene Ltd. Price hit a high of XXXXXX for the hour

### Price: $ [#](/topic/$6160hk/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$6160hk/time-series/close.tsv)  
The current upward price trend is likely due to increased investor confidence, market optimism, positive analyst ratings, and positive social community engagement regarding the company's partnerships and presentations, which is supported by the sentiment analysis and recent social posts.  

**1-Year High**: $XXXXXX on 2025-04-01  
**1-Year Low**: $XXXXX on 2024-07-19  
  
  
### AltRank: undefined [#](/topic/$6160hk/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$6160hk/time-series/alt_rank.tsv)  
BeiGene Ltd. is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXX  
**1-Year High**: XXX on 2025-02-17  
**1-Year Low**: XXX on 2025-02-28  
  
  
### Galaxy Score: XX [#](/topic/$6160hk/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$6160hk/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2024-11-14  
**1-Year Low**: XX on 2024-10-06  
  
  
### Engagements: XXX [#](/topic/$6160hk/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$6160hk/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX +89%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXX -XX%  
**1 Year**: XXXXXXXXX +17%  
**1-Year High**: XXXXXX on 2024-10-01  
**1-Year Low**: XXX on 2025-06-21  

| Social Network | X   | News | Reddit | YouTube | TikTok |
| -------------- | -   | ---- | ------ | ------- | ------ |
| Engagements    | XXX | X    | XX     | X       | XXX    |
  

  
  
### Mentions: XX [#](/topic/$6160hk/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$6160hk/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX +25%  
**1 Month**: XXX -XX%  
**6 Months**: XXX +7%  
**1 Year**: XXXXX +156%  
**1-Year High**: XX on 2025-03-03  
**1-Year Low**: X on 2024-09-08  

| Social Network | X  | News | Reddit | YouTube | TikTok |
| -------------- | -  | ---- | ------ | ------- | ------ |
| Mentions       | XX | X    | XX     | X       | X      |
  

  
  
### Creators: XX [#](/topic/$6160hk/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$6160hk/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning BeiGene Ltd. in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XX +29%  
**1 Month**: XXX -XX%  
**6 Months**: XXX +78%  
**1 Year**: XXX +141%  
**1-Year High**: XX on 2025-06-17  
**1-Year Low**: X on 2025-01-26  
  
  
### Sentiment: XX% [#](/topic/$6160hk/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$6160hk/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +27%  
**1 Month**: XX% -X%  
**6 Months**: XX% +38%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2024-07-22  
**1-Year Low**: XX% on 2024-09-12  

**Most Supportive Themes**
- **ASCO 2025 Presentation:** (54%) BeiGene's ASCO 2025 presentation is generating positive sentiment.
- **Pipeline Momentum:** (18%) BeiGene's pipeline momentum is viewed positively.
- **Annual Meeting Results:** (26%) BeiGene's Annual Meeting results are receiving positive sentiment.
  
**Most Critical Themes**
- **Failed Clinical Trial:** (1%)  A negative event impacting BeiGene's performance.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XXX     | XX% | X        | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
| TikTok  | XX       | X%  | XX      | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XXX     | XX% | X        | X% |
  

  
  
### Market Cap: $undefined [#](/topic/$6160hk/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$6160hk/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$6160hk/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-04-01  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-08  

**Top assets mentioned**
In the posts about BeiGene Ltd. in the last XX hours

[One Cash (ONC)](/topic/$onc)
[Novartis AG (NVS)](/topic/novartis)
[Alibaba Group (BABA)](/topic/$baba)
[Novartis AG (NVS)](/topic/$nvs)
[Elevance Health Inc (ELV)](/topic/$elv)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Kinder Morgan Inc (KMI)](/topic/$kmi)
[The Scotts Miracle-Gro Company (SMG)](/topic/$smg)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Merck & Co., Inc. (MRK)](/topic/$mrk)

**Top topics mentioned**
In the posts about BeiGene Ltd. in the last XX hours

[$bgne](/topic/$bgne), [china](/topic/china), [baba](/topic/baba), [$onc](/topic/$onc), [stocks healthcare](/topic/stocks-healthcare), [novartis](/topic/novartis), [$novnsw](/topic/$novnsw), [investment](/topic/investment), [coins stablecoin](/topic/coins-stablecoin), [$nwbo](/topic/$nwbo), [bloomberg](/topic/bloomberg), [coins ai](/topic/coins-ai), [$9999hk](/topic/$9999hk), [$9988hk](/topic/$9988hk), [$1810hk](/topic/$1810hk), [$baba](/topic/$baba), [approved](/topic/approved), [drugs](/topic/drugs), [$9992hk](/topic/$9992hk), [hang seng](/topic/hang-seng), [kong](/topic/kong), [hong kong](/topic/hong-kong), [$asmb](/topic/$asmb), [$zyme](/topic/$zyme), [$hcm](/topic/$hcm), [$nvs](/topic/$nvs), [longterm](/topic/longterm), [del](/topic/del), [coins healthcare](/topic/coins-healthcare), [$9626hk](/topic/$9626hk), [paypal](/topic/paypal), [$legn](/topic/$legn), [pinduoduo](/topic/pinduoduo), [$0700hk](/topic/$0700hk), [tencent](/topic/tencent), [$gmabco](/topic/$gmabco), [tak](/topic/tak), [biib biogen](/topic/biib-biogen), [$gmab](/topic/$gmab), [stocks technology](/topic/stocks-technology), [compound](/topic/compound), [immunotherapy](/topic/immunotherapy), [united states](/topic/united-states), [omega](/topic/omega), [#fyp](/topic/#fyp), [$elv](/topic/$elv), [$amgn](/topic/$amgn), [jersey](/topic/jersey), [xiaomi](/topic/xiaomi), [$2869hk](/topic/$2869hk), [$0285hk](/topic/$0285hk), [$1211hk](/topic/$1211hk), [byd](/topic/byd), [ibkr](/topic/ibkr), [hwm](/topic/hwm), [ebay](/topic/ebay), [$kmi](/topic/$kmi), [kinder](/topic/kinder), [don t](/topic/don-t), [jan](/topic/jan), [checkpoint](/topic/checkpoint), [pd](/topic/pd), [corporate finance](/topic/corporate-finance), [reverse](/topic/reverse), [nasdaq](/topic/nasdaq), [$6088hk](/topic/$6088hk), [fit hon](/topic/fit-hon), [$tcom](/topic/$tcom), [alibaba](/topic/alibaba), [stocks](/topic/stocks), [$smg](/topic/$smg), [$3850hour](/topic/$3850hour), [$2750hour](/topic/$2750hour), [applied](/topic/applied), [linkedin](/topic/linkedin), [$abbv](/topic/$abbv), [combo](/topic/combo), [$mrk](/topic/$mrk), [switzerland](/topic/switzerland), [ip](/topic/ip), [mcap](/topic/mcap), [india](/topic/india), [$afmd](/topic/$afmd), [pltr](/topic/pltr), [$zlab](/topic/$zlab), [$adma](/topic/$adma), [realtime](/topic/realtime), [smci](/topic/smci), [$ttd](/topic/$ttd), [npc](/topic/npc), [$indp](/topic/$indp), [convergence](/topic/convergence)

### Top Social Posts [#](/topic/$6160hk/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@BioPharmaBoi I saw BeiGene already has a competing molecule in blood cancer in phase X. Crowded space. In any case I bought a small amount. It's too exciting not to"  
[@BagelC47](/creator/x/BagelC47) on [X](/post/tweet/1946230097905955174) 2025-07-18 15:26:29 UTC XXX followers, X engagements


"Lupus Nephritis Pipeline 2025: FDA Updates Therapy Innovations and Clinical Trial Landscape Analysis by DelveInsight Roche Equillium BeiGene Janssen R&D Horizon Therapeutics #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"  
[@ABNewswire](/creator/x/ABNewswire) on [X](/post/tweet/1946213257771102525) 2025-07-18 14:19:34 UTC 1580 followers, XX engagements


"Lupus Nephritis Pipeline 2025: FDA Updates Therapy Innovations and Clinical Trial Landscape Analysis by DelveInsight Roche Equillium BeiGene Janssen R&D Horizon Therapeutics Novartis Roche"  
[@newjerseyheadli](/creator/x/newjerseyheadli) on [X](/post/tweet/1946201176762122525) 2025-07-18 13:31:33 UTC XXX followers, X engagements


"@BeOneMedicines a Swiss-based cancer treatment firm (formerly BeiGene) saw its stock climb XX per cent this week after RBC Capital upgraded its outlook. $ONC"  
[@MuggleheadMag](/creator/x/MuggleheadMag) on [X](/post/tweet/1946031923069120842) 2025-07-18 02:19:00 UTC 1817 followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BeiGene Ltd. Graphic BeiGene Ltd.

BeiGene's stock is climbing due to positive sentiment surrounding the ASCO 2025 presentation and pipeline momentum. China's biotech firms are advancing rapidly with AI catching up to US leaders in drug innovation.

About BeiGene Ltd.

BeiGene Ltd. is a biotechnology company focused on developing and commercializing innovative cancer medicines.

Insights #

  • BeiGene Ltd. sentiment is up XX% from the previous week.
  • BeiGene Ltd. creators is up XXXXX% from the previous week.
  • BeiGene Ltd. engagements is up XX% from the previous week.
  • BeiGene Ltd. mentions is up XX% from the previous week.
  • BeiGene Ltd. posts created is up XXX% from the previous week.
  • BeiGene Ltd. Price hit a high of XXXXXX for the hour

Price: $ #


Price Line Chart
Price 24-Hour Chart Data
The current upward price trend is likely due to increased investor confidence, market optimism, positive analyst ratings, and positive social community engagement regarding the company's partnerships and presentations, which is supported by the sentiment analysis and recent social posts.

1-Year High: $XXXXXX on 2025-04-01
1-Year Low: $XXXXX on 2024-07-19

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Chart Data
BeiGene Ltd. is currently AltRank #undefined based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXX on 2025-02-17
1-Year Low: XXX on 2025-02-28

Galaxy Score: XX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2024-11-14
1-Year Low: XX on 2024-10-06

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX +89%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX +17%
1-Year High: XXXXXX on 2024-10-01
1-Year Low: XXX on 2025-06-21

Social Network X News Reddit YouTube TikTok
Engagements XXX X XX X XXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +25%
1 Month: XXX -XX%
6 Months: XXX +7%
1 Year: XXXXX +156%
1-Year High: XX on 2025-03-03
1-Year Low: X on 2024-09-08

Social Network X News Reddit YouTube TikTok
Mentions XX X XX X X

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning BeiGene Ltd. in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Week: XX +29%
1 Month: XXX -XX%
6 Months: XXX +78%
1 Year: XXX +141%
1-Year High: XX on 2025-06-17
1-Year Low: X on 2025-01-26

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +27%
1 Month: XX% -X%
6 Months: XX% +38%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-22
1-Year Low: XX% on 2024-09-12

Most Supportive Themes

  • ASCO 2025 Presentation: (54%) BeiGene's ASCO 2025 presentation is generating positive sentiment.
  • Pipeline Momentum: (18%) BeiGene's pipeline momentum is viewed positively.
  • Annual Meeting Results: (26%) BeiGene's Annual Meeting results are receiving positive sentiment.

Most Critical Themes

  • Failed Clinical Trial: (1%) A negative event impacting BeiGene's performance.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX XX% XXX XX% X X%
News X X% X X% X X%
Reddit X X% XX X% X X%
YouTube X X% X X% X X%
TikTok XX X% XX XX% X X%
Total XX XX% XXX XX% X X%

Market Cap: $undefined #


Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-04-01
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-08

Top assets mentioned In the posts about BeiGene Ltd. in the last XX hours

One Cash (ONC) Novartis AG (NVS) Alibaba Group (BABA) Novartis AG (NVS) Elevance Health Inc (ELV) Amgen, Inc. (AMGN) Kinder Morgan Inc (KMI) The Scotts Miracle-Gro Company (SMG) AbbVie Inc (ABBV) Merck & Co., Inc. (MRK)

Top topics mentioned In the posts about BeiGene Ltd. in the last XX hours

$bgne, china, baba, $onc, stocks healthcare, novartis, $novnsw, investment, coins stablecoin, $nwbo, bloomberg, coins ai, $9999hk, $9988hk, $1810hk, $baba, approved, drugs, $9992hk, hang seng, kong, hong kong, $asmb, $zyme, $hcm, $nvs, longterm, del, coins healthcare, $9626hk, paypal, $legn, pinduoduo, $0700hk, tencent, $gmabco, tak, biib biogen, $gmab, stocks technology, compound, immunotherapy, united states, omega, #fyp, $elv, $amgn, jersey, xiaomi, $2869hk, $0285hk, $1211hk, byd, ibkr, hwm, ebay, $kmi, kinder, don t, jan, checkpoint, pd, corporate finance, reverse, nasdaq, $6088hk, fit hon, $tcom, alibaba, stocks, $smg, $3850hour, $2750hour, applied, linkedin, $abbv, combo, $mrk, switzerland, ip, mcap, india, $afmd, pltr, $zlab, $adma, realtime, smci, $ttd, npc, $indp, convergence

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"@BioPharmaBoi I saw BeiGene already has a competing molecule in blood cancer in phase X. Crowded space. In any case I bought a small amount. It's too exciting not to"
@BagelC47 on X 2025-07-18 15:26:29 UTC XXX followers, X engagements

"Lupus Nephritis Pipeline 2025: FDA Updates Therapy Innovations and Clinical Trial Landscape Analysis by DelveInsight Roche Equillium BeiGene Janssen R&D Horizon Therapeutics #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
@ABNewswire on X 2025-07-18 14:19:34 UTC 1580 followers, XX engagements

"Lupus Nephritis Pipeline 2025: FDA Updates Therapy Innovations and Clinical Trial Landscape Analysis by DelveInsight Roche Equillium BeiGene Janssen R&D Horizon Therapeutics Novartis Roche"
@newjerseyheadli on X 2025-07-18 13:31:33 UTC XXX followers, X engagements

"@BeOneMedicines a Swiss-based cancer treatment firm (formerly BeiGene) saw its stock climb XX per cent this week after RBC Capital upgraded its outlook. $ONC"
@MuggleheadMag on X 2025-07-18 02:19:00 UTC 1817 followers, XX engagements

BeiGene Ltd.
/topic/$6160hk